Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Neuronetics Q4 GAAP EPS $(0.19) Beats $(0.26) Estimate, Sales $20.31M Beat $19.85M Estimate

Author: Benzinga Newsdesk | March 05, 2024 08:31am
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.26) by 26.92 percent. This is a 36.67 percent increase over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $20.31 million which beat the analyst consensus estimate of $19.85 million by 2.34 percent. This is a 11.63 percent increase over sales of $18.20 million the same period last year.

Posted In: STIM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist